{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:52:36Z","timestamp":1760122356486},"reference-count":43,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":460,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Virol."],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1002\/jmv.23985","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T10:31:12Z","timestamp":1401359472000},"page":"1499-1506","source":"Crossref","is-referenced-by-count":21,"title":["Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFN\u03b1-2a and ribavirin in Iranian patients with chronic hepatitis C"],"prefix":"10.1002","volume":"86","author":[{"given":"Farzin","family":"Sadeghi","sequence":"first","affiliation":[{"name":"Department of Virology, School of Public Health; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Bokharaei-Salim","sequence":"additional","affiliation":[{"name":"Department of Virology; Iran University of Medical Sciences; Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Salehi-Vaziri","sequence":"additional","affiliation":[{"name":"Department of Virology, School of Public Health; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Hamidreza","family":"Monavari","sequence":"additional","affiliation":[{"name":"Department of Virology; Iran University of Medical Sciences; Tehran Iran"},{"name":"Department of Virology and Anti Microbial Resistant Research Center; Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Moayed","family":"Alavian","sequence":"additional","affiliation":[{"name":"Middle East Liver Disease Center; Tehran Iran"},{"name":"Iran Hepatitis Network; Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shima","family":"Salimi","sequence":"additional","affiliation":[{"name":"Middle East Liver Disease Center; Tehran Iran"},{"name":"Iran Hepatitis Network; Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rouhollah","family":"Vahabpour","sequence":"additional","affiliation":[{"name":"Department of Virology, School of Public Health; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Keyvani","sequence":"additional","affiliation":[{"name":"Department of Virology; Iran University of Medical Sciences; Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,5,29]]},"reference":[{"key":"10.1002\/jmv.23985-BIB0001|jmv23985-cit-0001","first-page":"5","article-title":"Hepatitis C virus infection: Epidemiology, risk factors and prevention strategies in public health in IR IRAN","volume":"3","author":"Alavian","year":"2010","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"10.1002\/jmv.23985-BIB0002|jmv23985-cit-0002","unstructured":"Alavian SM Jabbari H Daryani NE 2012"},{"key":"10.1002\/jmv.23985-BIB0003|jmv23985-cit-0003","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1478-3231.2010.02296.x","article-title":"Peginterferon alpha-2a and ribavirin treatment of patients with haemophilia and hepatitis C virus infection: A single-centre study of 367 cases","volume":"30","author":"Alavian","year":"2010","journal-title":"Liver Int"},{"key":"10.1002\/jmv.23985-BIB0004|jmv23985-cit-0004","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1478-3231.2008.01945.x","article-title":"What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C","volume":"29","author":"Alberti","year":"2009","journal-title":"Liver Int"},{"key":"10.1002\/jmv.23985-BIB0005|jmv23985-cit-0005","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/gut.2008.166348","article-title":"Gene expression and hepatitis C virus infection","volume":"58","author":"Asselah","year":"2009","journal-title":"Gut"},{"key":"10.1002\/jmv.23985-BIB0006|jmv23985-cit-0006","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1478-3231.2010.02283.x","article-title":"Hepatitis C: Viral and host factors associated with non-response to pegylated interferon plus ribavirin","volume":"30","author":"Asselah","year":"2010","journal-title":"Liver Int"},{"key":"10.1002\/jmv.23985-BIB0007|jmv23985-cit-0007","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/hep.21662","article-title":"Predictors of response of US veterans to treatment for the hepatitis C virus","volume":"46","author":"Backus","year":"2007","journal-title":"Hepatology"},{"key":"10.1002\/jmv.23985-BIB0008|jmv23985-cit-0008","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/00365549709008658","article-title":"Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group","volume":"29","author":"Bell","year":"1997","journal-title":"Scand J Infect Dis"},{"key":"10.1002\/jmv.23985-BIB0009|jmv23985-cit-0009","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/jmv.22044","article-title":"Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease","volume":"83","author":"Bokharaei-Salim","year":"2011","journal-title":"J Med Virol"},{"key":"10.1002\/jmv.23985-BIB0010|jmv23985-cit-0010","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1053\/j.gastro.2009.10.046","article-title":"Cell-type specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis C infection","volume":"138","author":"Chen","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1002\/jmv.23985-BIB0011|jmv23985-cit-0011","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1128\/JVI.02548-12","article-title":"TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation","volume":"87","author":"Di Pietro","year":"2013","journal-title":"J Virol"},{"key":"10.1002\/jmv.23985-BIB0012|jmv23985-cit-0012","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1172\/JCI70408","article-title":"Pegylated IFN-alpha regulates hepatic gene expression through transient Jak\/STAT activation","volume":"124","author":"Dill","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1002\/jmv.23985-BIB0013|jmv23985-cit-0013","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/hep.21853","article-title":"Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response","volume":"46","author":"Feld","year":"2007","journal-title":"Hepatology"},{"key":"10.1002\/jmv.23985-BIB0014|jmv23985-cit-0014","doi-asserted-by":"crossref","first-page":"e14697","DOI":"10.1371\/journal.pone.0014697","article-title":"ENCODE tiling array analysis identifies differentially expressed annotated and novel 5\u2032 capped RNAs in hepatitis C infected liver","volume":"6","author":"Folkers","year":"2011","journal-title":"PloS ONE"},{"key":"10.1002\/jmv.23985-BIB0015|jmv23985-cit-0015","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1002\/jmv.23985-BIB0016|jmv23985-cit-0016","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/hep.23011","article-title":"Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain","volume":"50","author":"Gao","year":"2009","journal-title":"Hepatology"},{"key":"10.1002\/jmv.23985-BIB0017|jmv23985-cit-0017","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1002\/jmv.23985-BIB0018|jmv23985-cit-0018","doi-asserted-by":"crossref","first-page":"153415","DOI":"10.1155\/2012\/153415","article-title":"TRI M22: A diverse and dynamic antiviral protein","volume":"2012","author":"Hattlmann","year":"2012","journal-title":"Mol Biol Int"},{"key":"10.1002\/jmv.23985-BIB0019|jmv23985-cit-0019","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.gastro.2010.04.049","article-title":"Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C","volume":"139","author":"Honda","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1002\/jmv.23985-BIB0020|jmv23985-cit-0020","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.21383","article-title":"Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C","volume":"44","author":"Honda","year":"2006","journal-title":"Hepatology"},{"key":"10.1002\/jmv.23985-BIB0021|jmv23985-cit-0021","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1126\/science.1140579","article-title":"Restriction of an extinct retrovirus by the human TRIM5alpha antiviral protein","volume":"316","author":"Kaiser","year":"2007","journal-title":"Science"},{"key":"10.1002\/jmv.23985-BIB0022|jmv23985-cit-0022","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/emmm.201100160","article-title":"Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins","volume":"3","author":"Kawai","year":"2011","journal-title":"EMBO Mol Med"},{"key":"10.1002\/jmv.23985-BIB0023|jmv23985-cit-0023","doi-asserted-by":"crossref","first-page":"e11290","DOI":"10.5812\/hepatmon.11290","article-title":"Occult hepatitis C virus infection in candidates for liver transplant with cryptogenic cirrhosis","volume":"13","author":"Keyvani","year":"2013","journal-title":"Hepat Mon"},{"key":"10.1002\/jmv.23985-BIB0024|jmv23985-cit-0024","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nrd2411","article-title":"The way forward in HCV treatment-Finding the right path","volume":"6","author":"Manns","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1002\/jmv.23985-BIB0025|jmv23985-cit-0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.coi.2010.10.021","article-title":"Tripartite-motif proteins and innate immune regulation","volume":"23","author":"McNab","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1002\/jmv.23985-BIB0026|jmv23985-cit-0026","first-page":"1372","article-title":"Processing of gene expression data generated by quantitative real-time RT-PCR","volume":"32","author":"Muller","year":"2002","journal-title":"Biotechniques"},{"key":"10.1002\/jmv.23985-BIB0027|jmv23985-cit-0027","doi-asserted-by":"crossref","first-page":"e6151","DOI":"10.5812\/hepatmon.6151","article-title":"Real response to therapy in chronic hepatitis C virus patients: A study from iran","volume":"12","author":"Namazee","year":"2012","journal-title":"Hepat Mon"},{"key":"10.1002\/jmv.23985-BIB0028|jmv23985-cit-0028","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nrmicro1248","article-title":"TRIM family proteins: Retroviral restriction and antiviral defence","volume":"3","author":"Nisole","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1002\/jmv.23985-BIB0029|jmv23985-cit-0029","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2413","article-title":"TRIM family proteins and their emerging roles in innate immunity","volume":"8","author":"Ozato","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1002\/jmv.23985-BIB0030|jmv23985-cit-0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0928-0197(96)00242-5","article-title":"Hepatitis C genotypes in Finland determined by RFLP","volume":"7","author":"Pohjanpelto","year":"1996","journal-title":"Clin Diagn Virol"},{"key":"10.1002\/jmv.23985-BIB0031|jmv23985-cit-0031","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/jmv.23985-BIB0032|jmv23985-cit-0032","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(03)15109-4","article-title":"Viral hepatitis C","volume":"362","author":"Poynard","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/jmv.23985-BIB0033|jmv23985-cit-0033","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1093\/emboj\/20.9.2140","article-title":"The tripartite motif family identifies cell compartments","volume":"20","author":"Reymond","year":"2001","journal-title":"EMBO J"},{"key":"10.1002\/jmv.23985-BIB0034|jmv23985-cit-0034","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1073\/pnas.0707882105","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C","volume":"105","author":"Sarasin-Filipowicz","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jmv.23985-BIB0035|jmv23985-cit-0035","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/JVI.01810-10","article-title":"Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection","volume":"85","author":"Singh","year":"2011","journal-title":"J Virol"},{"key":"10.1002\/jmv.23985-BIB0036|jmv23985-cit-0036","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1053\/jhep.2003.09024","article-title":"Hepatitis C virus and liver disease: Global transcriptional profiling and identification of potential markers","volume":"38","author":"Smith","year":"2003","journal-title":"Hepatology"},{"key":"10.1002\/jmv.23985-BIB0037|jmv23985-cit-0037","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nature02343","article-title":"The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys","volume":"427","author":"Stremlau","year":"2004","journal-title":"Nature"},{"key":"10.1002\/jmv.23985-BIB0038|jmv23985-cit-0038","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1073\/pnas.202608199","article-title":"Genomic analysis of the host response to hepatitis C virus infection","volume":"99","author":"Su","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jmv.23985-BIB0039|jmv23985-cit-0039","doi-asserted-by":"crossref","first-page":"14891","DOI":"10.1074\/jbc.270.25.14891","article-title":"Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression","volume":"270","author":"Tissot","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1002\/jmv.23985-BIB0040|jmv23985-cit-0040","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.22749","article-title":"Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma","volume":"49","author":"Ura","year":"2009","journal-title":"Hepatology"},{"key":"10.1002\/jmv.23985-BIB0041|jmv23985-cit-0041","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1128\/JVI.77.7.3898-3912.2003","article-title":"Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication","volume":"77","author":"Wang","year":"2003","journal-title":"J Virol"},{"key":"10.1002\/jmv.23985-BIB0042|jmv23985-cit-0042","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jmv.23985-BIB0043|jmv23985-cit-0043","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/jhep.2003.50184","article-title":"Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line","volume":"37","author":"Zhu","year":"2003","journal-title":"Hepatology"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.23985","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jmv.23985\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T15:30:42Z","timestamp":1625326242000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.23985"}},"subtitle":["TRIM22 Expression and Response to HCV Antiviral Therapy"],"short-title":[],"issued":{"date-parts":[[2014,5,29]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"URL":"https:\/\/doi.org\/10.1002\/jmv.23985","relation":{},"ISSN":["0146-6615"],"issn-type":[{"value":"0146-6615","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5,29]]}}}